台股 » 個股 » 國光生 » 籌碼相關 » 券商分點績效

國光生

(4142)
可現股當沖
  • 股價
    28.10
  • 漲跌
    ▼0.15
  • 漲幅
    -0.53%
  • 成交量
    739
  • 產業
    上市 生技醫療類股
  • 633人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
國光生 (4142)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/18 ~ 2024/04/25     後一日»

券商獲利排行 - 2024/04/18 ~ 2024/04/25

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  2.64%1,228.41211,107.4-1,0475501,59729.128.929.228.1
  0.97%224.7139.285.5-17863481328.528.428.628.1
  4.75%129.366.163.3-60359528.627.329.228.1
  5.62%111.420.590.9-53146729.628.429.828.1
  2.63%98.396.31.9341319728.5282928.1
  3.30%97.9097.9-102010229.1029.128.1
  4.45%96.977.91925785327.927.328.828.1
  0.44%91.892.3-0.4-2085457532827.928.128.1
  3.58%87.882.94.928865828.527.929.428.1
  4.66%84.522.562.1-43196229.328.429.528.1
  1.70%74.875.4-0.6-215816027.527.327.828.1
  4.14%64.63.661.1-4395329.429.129.528.1
  2.26%64.424.340-45539928.828.52928.1
  6.85%64.226.437.8-21113229.327.529.928.1
  6.02%63063-3503529.9029.928.1
  1.26%62.6-10.272.9-1373617428.728.928.628.1
  6.00%59.2059.2-3303329.9029.928.1
  2.90%55.4055.4-6426629292928.1
  3.93%55.118.436.741511027.527.229.128.1
  4.11%5319.533.6-35104528.727.129.128.1
  4.38%52.519.333.2-22184129.228.529.528.1
  3.00%50.3446.3-5265828.928.32928.1
  4.28%47.732.61519402127.827.328.928.1
  5.15%45.437.28.2-7233128.427.529.128.1
  3.92%45.115.329.8-30104028.827.629.128.1
  4.92%44.337.96.49322328.127.42928.1
  2.61%44.25.638.6-5275928.82828.828.1
  5.06%41.94.137.8-2342829.528.629.728.1
  2.91%39.7039.75050027.327.3028.1
  4.17%39.327.611.713342127.727.228.528.1
  4.10%35.217.517.7-18113028.627.42928.1
  5.78%34.50.334.2-1912029.929.629.928.1
  1.75%32.90.732.2-40246528.928.928.928.1
  2.37%32.5032.55050027.527.5028.1
  5.63%323200202028.427.629.228.1
  1.80%31.7229.748641627.527.527.628.1
  2.93%30.53.327.2-287362928.62928.1
  1.86%29.814.915-19375628.728.528.928.1
  4.42%27.324.82.53221828.127.528.828.1
  3.57%27.10.926.2-2332629.22929.228.1
  1.74%26.38.318.1-34195328.528.228.628.1
  1.01%25.639.3-13.731885728.828.529.228.1
  2.06%25.526.5-0.9-5404527.627.327.928.1
  4.14%25.50.824.7-1922129.42929.428.1
  3.40%24.914.210.6-6182529.328.829.628.1
  3.34%23.419.14.3-1015252827.328.528.1
  2.55%22.54.717.82932327.627.529.128.1
  2.73%21.911.310.6-12162828.728.32928.1
  2.91%21.84.916.9-1972628.828.32928.1
  1.91%21.7-0.622.3-23163929.129.129.128.1

券商虧損排行 - 2024/04/18 ~ 2024/04/25

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -7.09%-220.1-204.8-15.4-238610928.529.827.428.1
  -1.55%-177.80.8-178.6-3783641427.627.627.628.1
  -5.41%-176.7-4.1-172.6106110429.729.728.728.1
  -6.27%-175.7-171.8-3.95100952828.927.128.1
  -1.88%-108.3-97.2-11.11520218628.528.828.328.1
  -2.94%-80.9-79.9-19999027.828.227.328.1
  -4.89%-80.1-72.5-7.65575128.729.427.928.1
  -6.39%-78.6-78.60044442828.927.128.1
  -0.93%-76.916.4-93.42422914928.528.528.828.1
  -2.64%-76.3-63.5-12.8-574410228.329.327.928.1
  -5.79%-74-2.8-71.24243129.729.82728.1
  -6.53%-62.9-59.4-3.53343128.429.327.428.1
  -3.25%-59.2-26-33.231633228.929.228.428.1
  -6.66%-59.1-51.9-7.25312628.629.527.528.1
  -4.22%-54.2-7.1-47.13644729.229.428.428.1
  -5.48%-52.1-46.7-5.4-528342828.927.228.1
  -5.71%-51.2-50.5-0.7132312828.827.228.1
  -4.35%-46-5.3-40.7-3723927.129.72728.1
  -3.18%-45.7-13.4-32.437501328.82927.928.1
  -3.10%-45.5-0.4-45.1-4775427.127.227.128.1
  -3.36%-44.8-32-12.8946362929.428.528.1
  -4.02%-44-13.9-30.13038828.829.127.428.1
  -5.55%-43.8-40.2-3.6-5232828.229.127.428.1
  -7.26%-43.6-42.4-1.2-2192128.629.727.528.1
  -1.76%-41.1-43.22.2-28548228.52928.228.1
  -2.85%-40.2-11-29.234491528.82928.228.1
  -3.33%-38.8-18.9-2027411428.528.827.528.1
  -2.58%-38.11.1-39.24851328.928.929.328.1
  -2.26%-36.4-2.3-34.15056528.728.828.328.1
  -0.35%-36.123.8-59.8-2789337127.827.627.928.1
  -3.60%-33.7-15.5-18.212322029.329.628.828.1
  -4.42%-33.30-33.3-2802826.9026.928.1
  -2.78%-30.7-10.7-2017382129.129.328.828.1
  -1.73%-29.9-20.1-9.824613728.328.52828.1
  -6.54%-29.7-22.6-7.26161028.429.32728.1
  -3.79%-29.7-3.3-26.52427329.129.228.128.1
  -3.19%-29.2-15.3-13.818321428.528.927.828.1
  -0.66%-29-20.7-8.3661558928.128.22828.1
  -3.31%-28.5-11.7-16.818301128.72927.928.1
  -5.11%-27.9-19.4-8.47191228.729.327.728.1
  -3.63%-27.8-16.7-11.215271228.428.827.528.1
  -2.51%-27.50-27.53838028.828.827.328.1
  -2.09%-27.2-16.8-10.423462328.328.627.828.1
  -1.49%-27-6.7-20.45764728.428.527.528.1
  -2.81%-26.8-23.3-3.53333028.929.328.528.1
  -2.34%-26.1-23.9-2.22393628.528.828.228.1
  -4.08%-25.9-11.9-1412221028.929.328.128.1
  -2.51%-25.5-16.9-8.67352829.129.328.728.1
  -3.04%-25-12.7-12.32029928.428.727.328.1
  -4.88%-24.8-20.5-4.35181328.32927.428.1
國光生去年營運轉虧 今年拚重回成長軌道Anue鉅亨-2024/03/13
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
國光生 相關文章